142 related articles for article (PubMed ID: 8956134)
1. Quantitative measurements with localized 1H MR spectroscopy in children with Canavan's disease.
Wittsack HJ; Kugel H; Roth B; Heindel W
J Magn Reson Imaging; 1996; 6(6):889-93. PubMed ID: 8956134
[TBL] [Abstract][Full Text] [Related]
2. [Magnetic resonance tomography and localized proton spectroscopy in 2 siblings with Canavan's disease].
Engelbrecht V; Rassek M; Gärtner J; Kahn T; Mödder U
Rofo; 1995 Sep; 163(3):238-44. PubMed ID: 7548871
[TBL] [Abstract][Full Text] [Related]
3. Use of localized proton nuclear magnetic resonance spectroscopy in Canavan's disease.
Aydinli N; Calişkan M; Calay M; Ozmen M
Turk J Pediatr; 1998; 40(4):549-57. PubMed ID: 10028864
[TBL] [Abstract][Full Text] [Related]
4. Metabolic changes in the knockout mouse for Canavan's disease: implications for patients with Canavan's disease.
Surendran S; Matalon KM; Szucs S; Tyring SK; Matalon R
J Child Neurol; 2003 Sep; 18(9):611-5. PubMed ID: 14572139
[TBL] [Abstract][Full Text] [Related]
5. Localized 1H NMR spectroscopy in Canavan's disease: a report of two cases.
Austin SJ; Connelly A; Gadian DG; Benton JS; Brett EM
Magn Reson Med; 1991 Jun; 19(2):439-45. PubMed ID: 1881331
[TBL] [Abstract][Full Text] [Related]
6. Canavan's spongiform leukodystrophy: a clinical anatomy of a genetic metabolic CNS disease.
Baslow MH
J Mol Neurosci; 2000 Oct; 15(2):61-9. PubMed ID: 11220786
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging in juvenile Canavan disease.
Toft PB; Geiss-Holtorff R; Rolland MO; Pryds O; Müller-Forell W; Christensen E; Lehnert W; Lou HC; Ott D; Hennig J
Eur J Pediatr; 1993 Sep; 152(9):750-3. PubMed ID: 8223809
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of Canavan's disease: from human to mouse.
Surendran S; Matalon KM; Tyring SK; Matalon R
J Child Neurol; 2003 Sep; 18(9):604-10. PubMed ID: 14572138
[TBL] [Abstract][Full Text] [Related]
9. Case 15-1998: elevated N-acetylaspartic acid activity in Canavan's disease.
Breslau J
N Engl J Med; 1998 Aug; 339(9):636. PubMed ID: 9722443
[No Abstract] [Full Text] [Related]
10. Regulation of NAA-synthesis in the human brain in vivo: Canavan's disease, Alzheimer's disease and schizophrenia.
Harris K; Lin A; Bhattacharya P; Tran T; Wong W; Ross B
Adv Exp Med Biol; 2006; 576():263-73; discussion 361-3. PubMed ID: 16802718
[No Abstract] [Full Text] [Related]
11. Mild-onset presentation of Canavan's disease associated with novel G212A point mutation in aspartoacylase gene.
Janson CG; Kolodny EH; Zeng BJ; Raghavan S; Pastores G; Torres P; Assadi M; McPhee S; Goldfarb O; Saslow B; Freese A; Wang DJ; Bilaniuk L; Shera D; Leone P
Ann Neurol; 2006 Feb; 59(2):428-31. PubMed ID: 16437572
[TBL] [Abstract][Full Text] [Related]
12. Atypical MRI findings in Canavan disease: a patient with a mild course.
Yalcinkaya C; Benbir G; Salomons GS; Karaarslan E; Rolland MO; Jakobs C; van der Knaap MS
Neuropediatrics; 2005 Oct; 36(5):336-9. PubMed ID: 16217711
[TBL] [Abstract][Full Text] [Related]
13. Restricted diffusion in Canavan disease.
Srikanth SG; Chandrashekar HS; Nagarajan K; Jayakumar PN
Childs Nerv Syst; 2007 Apr; 23(4):465-8. PubMed ID: 17219235
[TBL] [Abstract][Full Text] [Related]
14. Use of computed tomography, magnetic resonance imaging, and localized 1H magnetic resonance spectroscopy in Canavan's disease: a case report.
Marks HG; Caro PA; Wang ZY; Detre JA; Bogdan AR; Gusnard DA; Zimmerman RA
Ann Neurol; 1991 Jul; 30(1):106-10. PubMed ID: 1929222
[TBL] [Abstract][Full Text] [Related]
15. Proton NMR spectroscopy of Canavan's disease.
Barker PB; Bryan RN; Kumar AJ; Naidu S
Neuropediatrics; 1992 Oct; 23(5):263-7. PubMed ID: 1454147
[TBL] [Abstract][Full Text] [Related]
16. Uncoupling N-acetylaspartate from brain pathology: implications for Canavan disease gene therapy.
von Jonquieres G; Spencer ZHT; Rowlands BD; Klugmann CB; Bongers A; Harasta AE; Parley KE; Cederholm J; Teahan O; Pickford R; Delerue F; Ittner LM; Fröhlich D; McLean CA; Don AS; Schneider M; Housley GD; Rae CD; Klugmann M
Acta Neuropathol; 2018 Jan; 135(1):95-113. PubMed ID: 29116375
[TBL] [Abstract][Full Text] [Related]
17. Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease.
Madhavarao CN; Arun P; Moffett JR; Szucs S; Surendran S; Matalon R; Garbern J; Hristova D; Johnson A; Jiang W; Namboodiri MA
Proc Natl Acad Sci U S A; 2005 Apr; 102(14):5221-6. PubMed ID: 15784740
[TBL] [Abstract][Full Text] [Related]
18. Natural history of Canavan disease revealed by proton magnetic resonance spectroscopy (1H-MRS) and diffusion-weighted MRI.
Janson CG; McPhee SW; Francis J; Shera D; Assadi M; Freese A; Hurh P; Haselgrove J; Wang DJ; Bilaniuk L; Leone P
Neuropediatrics; 2006 Aug; 37(4):209-21. PubMed ID: 17177147
[TBL] [Abstract][Full Text] [Related]
19. Dietary treatment proposed for Canavan's disease.
Chen V
Lancet Neurol; 2005 May; 4(5):273. PubMed ID: 15861552
[No Abstract] [Full Text] [Related]
20. A new metabolite contributing to N-acetyl signal in 1H MRS of the brain in Salla disease.
Varho T; Komu M; Sonninen P; Holopainen I; Nyman S; Manner T; Sillanpää M; Aula P; Lundbom N
Neurology; 1999 May; 52(8):1668-72. PubMed ID: 10331697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
